These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23193980)

  • 1. Identifying and managing patients at high risk for fractures: conclusions from the second Spanish multidisciplinary forum-parathyroid hormone use in osteoporotic patients at high risk for fractures.
    Jódar Gimeno E
    Drugs R D; 2012 Dec; 12(4):199-206. PubMed ID: 23193980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH analogues and osteoporotic fractures.
    Verhaar HJ; Lems WF
    Expert Opin Biol Ther; 2010 Sep; 10(9):1387-94. PubMed ID: 20629581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefits and risks of parathyroid hormone treatment in compliant osteoporotic patients. A Danish national register based cohort study.
    Thorsteinsson AL; Hansen L; Vestergaard P; Eiken P
    Arch Osteoporos; 2018 May; 13(1):50. PubMed ID: 29717390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women.
    Peichl P; Holzer LA; Maier R; Holzer G
    J Bone Joint Surg Am; 2011 Sep; 93(17):1583-7. PubMed ID: 21915572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
    Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
    Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone and bone healing.
    Ellegaard M; Jørgensen NR; Schwarz P
    Calcif Tissue Int; 2010 Jul; 87(1):1-13. PubMed ID: 20428858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
    Takeuchi Y
    Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parathyroid hormone for osteroporsis: why and who to treat?].
    Ferrari S; Rizzoli R
    Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in designing and testing a "cure" for osteoporosis.
    Cummings S
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):408. PubMed ID: 15758283
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of teriparatide in osteoporotic fracture patients.
    Collinge C; Favela J
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone analogues in the treatment of osteoporosis.
    Kraenzlin ME; Meier C
    Nat Rev Endocrinol; 2011 Jul; 7(11):647-56. PubMed ID: 21750510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential therapy in the treatment of osteoporosis.
    Boonen S; Milisen K; Gielen E; Vanderschueren D
    Curr Med Res Opin; 2011 Jun; 27(6):1149-55. PubMed ID: 21466276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
    Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
    Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anti-osteoporosis medications on fracture healing.
    Jørgensen NR; Schwarz P
    Curr Osteoporos Rep; 2011 Sep; 9(3):149-55. PubMed ID: 21698357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of osteoporosis with PTH: treatment and prescription patterns in Europe.
    Hosking D; Alonso CG; Brandi ML
    Curr Med Res Opin; 2009 Jan; 25(1):263-70. PubMed ID: 19210157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTH1-34 improves bone healing by promoting angiogenesis and facilitating MSCs migration and differentiation in a stabilized fracture mouse model.
    Jiang X; Xu C; Shi H; Cheng Q
    PLoS One; 2019; 14(12):e0226163. PubMed ID: 31821371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of PTH 1-84 for fracture repair: an exciting prospect: Commentary on an article by Peter Peichl, MD, et al.: "Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women".
    Einhorn TA
    J Bone Joint Surg Am; 2011 Sep; 93(17):e102(1-2). PubMed ID: 21915555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.